Winchester, MA, United States of America

Anna Aldovini

This inventor holds 10 USPTO granted patents. Top assignees: Whitehead Institute for Biomedical Research, Beth Israel Hospital, Children's Medical Center Corporation. Active years: 1997-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Aldovini. Retrieved from https://idiyas.com/inventor/anna-aldovini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 90.0

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 60(Granted Patents)


Location History:

  • Winchester, MA (US) (1997 - 2002)
  • Weston, MA (US) (2000 - 2006)

Company Filing History:


Years Active: 1997-2006

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Aldovini

Introduction

Anna Aldovini is a prominent inventor based in Winchester, Massachusetts, known for her significant contributions to biomedical research. With a total of 10 patents to her name, she has made remarkable strides in the field of virology and mycobacterial research. Her work focuses on developing innovative solutions to combat infectious diseases, particularly those caused by HIV and mycobacteria.

Latest Patents

One of Aldovini's latest patents involves the creation of DNA vectors containing mutated HIV proviruses. This invention pertains to non-infectious HIV viral particles that are designed to minimize the risk of genetic reversion to an infectious virus while retaining the essential protein content and immunogenic properties of a wild-type virion. The non-infectious particles are produced by introducing specific inactivating mutations into the native viral genome. These mutations are strategically placed to ensure that the altered viral genome can express proteins that assemble into non-infectious particles, which contain immunogenic components of the virus but are incapable of infecting cells.

Another significant patent focuses on homologously recombinant slow-growing mycobacteria. This method involves transforming slow-growing mycobacteria, such as BCG, and manipulating their genomic DNA through homologous recombination. The invention allows for the production of homologously recombinant slow-growing mycobacteria with integrated heterologous DNA at a homologous locus, providing valuable tools for genetic research and potential therapeutic applications.

Career Highlights

Aldovini has had a distinguished career, working with esteemed institutions such as the Whitehead Institute for Biomedical Research and Beth Israel Hospital. Her research has not only advanced scientific understanding but has also paved the way for new therapeutic strategies in the fight against infectious diseases.

Collaborations

Throughout her career, Aldovini has collaborated with notable scientists, including Richard A. Young and Michael A. O'Donnell. These collaborations have enriched her research and contributed to the development of innovative solutions in her field.

Conclusion

Anna Aldovini's contributions to biomedical research exemplify the impact of innovation in addressing global health challenges. Her patents and research efforts continue to inspire advancements in the understanding and treatment of infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…